G
GRCE
Grace Therapeutics, Inc
1.930
+0.015+0.78%After Hours: 1.930 0.000 0.00%19:30 10/23 EDT
OPEN/PREV CLOSE1.910/1.915
TODAY RANGE1.880-1.950
VOL47.22K
MARKET CAP40.60M
52 WEEK RANGE1.790-5.18
AVG VOL (3M)162.80K
% TURNOVER0.22%
TURNOVER--
P/E (TTM)-1.6381
% RANGE3.66%
EPS(TTM)-1.1782
P/E(FORWARD)-0.3129
P/B0.6515
BVPS2.963
DIVIDEND--
P/S33.92
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP33.02M
SHARES OUTSTANDING21.04M
NEXT EARNINGS--
FREE FLOAT17.11M
LOT SIZE1
EX-DATE07/10/2023
News
Press Releases
Financial Reports
Profile
TipRanks·10/17 13:01
Cytokinetics, International Seaways, BJ’s, Grace, PBF Shake-Up
TipRanks·10/10 13:01
Insider Moves in PIMCO, Strive, Cencora, Grace, Banco Bradesco
TipRanks·10/06 02:01
Major Investor Quietly Boosts Stake in Grace Therapeutics
TipRanks·10/03 13:01
Bumble, PIMCO Dynamic, Cytokinetics, Medifast, Grace
TipRanks·10/02 02:03
Major Investor Quietly Boosts Stake in Grace Therapeutics
TipRanks·09/18 20:33
Grace Therapeutics Shareholders Back Board, Pay and Auditor
TipRanks·09/11 02:04
Insiders Double Down on Grace Therapeutics in Bold Buying Spree
NASDAQ·09/10 18:48
Thursday 9/10 Insider Buying Report: SEI, GRCE
TipRanks·08/24 20:15
Grace Therapeutics files to sell 4.76M shares of common stock for holders
TipRanks·08/20 02:08
Major Investor Quietly Boosts Stake in Grace Therapeutics With Fresh Buy-In
TipRanks·08/18 13:15
Grace Therapeutics (GRCE) Receives a Rating Update from a Top Analyst
Seeking Alpha·08/13 19:07
Grace Therapeutics GAAP EPS of -$0.91
Benzinga·08/13 12:23
Grace Therapeutics Q1 EPS $(0.91) Misses $(0.18) Estimate